GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract HHSN272201800003CDUKE UNIVERSITY

Overview

Award facts

Net obligations
$6.15M
$6,148,488of $6.15M potential value
Outlays (paid to date)
$3.27M
$3.27M paid of $6.15M obligated$3,271,202
Period of performance
Dec 22, 2017 to Dec 14, 2024
Ended
Modifications
17
Latest action Jul 23, 2026
Contract type
Definitive contract
PIID HHSN272201800003C

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IGF::OT::IGF NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT

Dates and value

Award date
Signed on Dec 22, 2017
Current value
$6,148,488Base and exercised options
Potential value (if all options are exercised)
$6,148,488

Obligations by fiscal year of action

  • FY2026: -$30,371 (de-obligation)
  • FY2025: -$232,334 (de-obligation)
  • FY2024: $807,276
  • FY2023: $777,583
  • FY2022: $784,442
  • FY2021: $1,283,020
  • FY2020: $1,320,678
  • FY2019: $726,266
Show all 9 years
  • FY2018: $711,928

Total across 9 fiscal years: $6,148,488

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 23, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationDURHAM, NC
UEITP7EK8DZV6N5
CAGE code4B478
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt
Parent companyDUKE UNIVERSITY

Business types and certifications

Nonprofit organizationEducational institutionTax-exempt corporation

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Durham, North Carolina 27701-3606
Congressional district (place of performance)
NC-04As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
2

Solicitation and notices

Solicitation ID
NIAIDDAIDSNIHAI2016075(as reported)

Contract details

Subcontracting plan
Individual subcontract planF
Major program
Nonhuman primate core virology laboratory for aids vaccine research and development
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Dec 22, 2017Base obligation at award: $711,928
Latest action
Jul 23, 2026 — Funding onlyModification P00017; obligation change -$30,371; funding only: changes obligations, not scope
Latest substantive action
Dec 11, 2023 — Option exercisedModification P00014; obligation change +$824,248
Latest funding action
Jul 23, 2026 — Funding onlyModification P00017; obligation change -$30,371; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Option exercised6
  • Other administrative action6
  • Funding only4
  • New work added (outside scope)1
18 actions recorded, Dec 22, 2017 to Jul 23, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$30,371
Latest action: change in base and all options
-$30,371

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Other U.S. entity (e.g. government)B
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
18

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2018/2018-0885-000
  • 075-2019/2019-0885-000
  • 075-2020/2020-0885-000
  • 075-2020/2024-0885-000
  • 075-2021/2021-0885-000
  • 075-2022/2022-0885-000
Show all 8 accounts
  • 075-2023/2023-0885-000
  • 075-2024/2024-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • N: Emergency P.L. 116-136
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
COVID-19 supplemental obligations
$1,091,701
COVID-19 supplemental outlays
$763,571